Sign up

ATEV for Dialysis Access

Clinical caseNephrology2 min
ATEV for Dialysis Access

A patient with end-stage kidney disease is receiving haemodialysis via an indwelling catheter and is being assessed for creation of longer-term haemodialysis access. She is a candidate for either an autogenous arteriovenous fistula or an arteriovenous graft.

Based on this abstract, what does the evidence support when comparing human acellular tissue engineered vessel (ATEV) with autogenous arteriovenous fistula (AVF) for haemodialysis access over 1 year?